Relier Pairs Diabetes Oral MedsVersion en ligne NUr115 Oral Diabetic Agents par Concetta Fiorentino 1 Inhibit production of glucose by the liver. 2 Drug to drug interaction with NSAIDS. 3 Stimulate pancreas to secrete insulin. 4 Enhances glucose-dependent insulin secretion. 5 Sensitize body tissue to insulin: stimulates insulin receptor sites. 6 Increase and prolong the action of the hormone that increases insulin release and decreases glucagon levels. 7 Usually given once a day. 8 Prevents kidneys from reabsorbing glucose. 9 Possible side-effect of impaired platelet function. 10 Stimulate beta cells of the pancreas. 11 Do not increased insulin secretion. Januvia Glucagon-like peptide-1 agonist (liraglutide/Victoza,, dulaglutide/Trulicity) Thiazolidinediones (pioglitazone (actos, rosiglitazone/Avandia) Non-sulfonylurea insulin secretagogues (repaglinide/Prandin, nateglinide/Starlix) Alpha-glucosidase inhibitors (acarbose/Precose, miglitol (Glyset) glipizide Biguanides (metformin (Glucophage) Metformin with glyburide (Glucovance) Avandia Dipeptidyl Pepidase-4 Inhibitors (sitagliptin/Januvia, vildagliptin /Galvus) Sodium-glucose co-transporter 2 inhibitors (empagliflozin/Jardiance Second generation sulfonylureas (glipizide (Glucotrol) Glyburide (DiaBeta) Glimepiride (Amaryl)
Créer jeu